Alnylam Pharmaceuticals
ALNY
#650
Rank
A$56.36 B
Marketcap
A$422.17
Share price
-0.61%
Change (1 day)
-15.42%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company